The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists
- 30 November 2001
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 44 (5) , 397-409
- https://doi.org/10.1006/phrs.2001.0870
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.Diabetes, 1999
- Characterization of the Imidazoline Binding Site Involved in Regulation of Insulin Secretionfn1Annals of the New York Academy of Sciences, 1995
- No Evidence for Mutations in a Putative β-Cell ATP-Sensitive K+ Channel Subunit in MODY, NIDDM, or GDMDiabetes, 1995
- Identification in Islets of Langerhans of a New Rat α2-Adrenergic ReceptorDiabetes, 1994
- Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080British Journal of Pharmacology, 1993
- Stimulation of insulin secretion by the imidazoline α2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding siteEuropean Journal of Pharmacology, 1993
- Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in ratsEuropean Journal of Pharmacology, 1992
- The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cellsEuropean Journal of Pharmacology, 1991
- Clonidine inhibits ATP‐sensitive K+channels in mouse pancreatic β‐cellsBritish Journal of Pharmacology, 1991
- Stimulation of insulin secretion by efaroxan may involve interaction with potassium channelsEuropean Journal of Pharmacology, 1990